Innophos Holdings Inc - Conference Presentation Calls

Innophos Holdings Inc. announced unaudited consolidated earnings results for the third quarter September 30, 2009. Net sales for the third quarter 2009 were $161.9 million, a decrease of $129.9 million, or 44.5%, as compared to $291.8 million for the same period in 2008. Operating income for the third quarter 2009 was $28.5 million, a decrease of $84.4 million, or 74.8%, versus $112.9 million for the comparable period in 2008. The decrease in operating income was primarily due to the noted selling price and volume declines offset partly by raw material savings. Net income for the third quarter 2009 was $15.1 million, a decrease of $64.6 million compared to $79.7 million for the same period in 2008. Diluted earnings per share for the third quarter 2009 were $0.69 compared to $3.62 for the third quarter 2008 and $0.81 for the second quarter 2009. Net debt at the end of the third quarter 2009 was $121.7 million, a decrease of $30.6 million from $152.3 million at June 30, 2009. Capital expenditures for the third quarter 2009 were $5.1 million compared to $4.0 million for the third quarter 2008. Net cash provided from operating activities was $155.9 million compared to $131.4 million for the same period a year ago. Income before income taxes was $22.7 million compared to $105.0 million for the same period a year ago. Capital expenditures for 2009 are now expected to finish in the $18 to $20 million range; lower than previously indicated, partly due to timing differences on project spending and partly a result of reprioritizing projects consistent with present business needs. Spending will continue on the food grade quality conversion of Mexico's phosphoric acid that is still targeted for first quarter 2010 completion.

Innophos Holdings Inc expected to Report Fiscal Year 2009 Results on February 8, 2010. This event was calculated by Capital IQ (Created on November 2, 2009).